Ignite Creation Date:
2025-12-24 @ 9:34 PM
Ignite Modification Date:
2026-04-07 @ 3:56 AM
Study NCT ID:
NCT04526132
Status:
COMPLETED
Last Update Posted:
2023-05-22
First Post:
2020-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China
Sponsor:
Shijiazhuang Yiling Pharmaceutical Co. Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BALF-PAIN-3001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None